Creo Medical Group PLC (LON:CREO)
13.50p
Spriggl Score: Weak— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Premium placing signals confidence, yet going-concern risk persists until Europe sale completes and losses cease.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Creo Medical Group PLC
Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise …
- Sector:
- Healthcare
- Industry:
- Medical Devices
- Market Cap:
- £64.4M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Creo Medical Group PLC and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free